|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.380 USD | -2.13% |
|
+2.99% | - |
| Feb. 11 | Top Midday Gainers | MT |
| Feb. 10 | Neuronetics Reports Preliminary Fiscal Q4, 2025 Results | MT |
Company Valuation: Neuronetics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 210.8 | 117.6 | 187 | 83.91 | 89.6 | 94.51 | 94.51 | - |
| Change | - | -44.22% | 59.02% | -55.13% | 6.79% | 5.48% | 0% | - |
| Enterprise Value (EV) | 210.8 | 117.6 | 187 | 83.91 | 89.6 | 94.51 | 94.51 | 94.51 |
| Change | - | -44.22% | 59.02% | -55.13% | 6.79% | 5.48% | 0% | 0% |
| P/E ratio | -7.61x | -3.66x | -4.98x | -2.76x | -1.18x | -2.33x | -3x | -4.22x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | -0.4x | 0.1x | -0x | 0x | 0.1x | 0.1x |
| Capitalization / Revenue | 4.28x | 2.13x | 2.87x | 1.18x | 1.2x | 0.64x | 0.58x | 0.51x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.64x | 0.58x | 0.51x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -4.52x | -8.36x | -11.5x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.97x | -3.9x | -5.02x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.46 | -1.22 | -1.38 | -1.05 | -1.37 | -0.5933 | -0.46 | -0.3267 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 49.24 | 55.31 | 65.21 | 71.35 | 74.5 | 148.3 | 164.2 | 184.3 |
| EBITDA 1 | -21.99 | -26.11 | -24.72 | -28.55 | -21.27 | -20.9 | -11.3 | -8.2 |
| EBIT 1 | -22.31 | -27.56 | -35.11 | -30.55 | -34.04 | -31.77 | -24.2 | -18.84 |
| Net income 1 | -27.45 | -31.19 | -37.16 | -30.19 | -43.2 | -39.29 | -32.4 | -24.14 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 11.110 | 4.460 | 6.870 | 2.900 | 1.610 | 1.380 | 1.380 | 1.380 |
| Nbr of stocks (in thousands) | 18,975 | 26,368 | 27,221 | 28,933 | 55,652 | 68,486 | 68,486 | - |
| Announcement Date | 3/2/21 | 3/8/22 | 3/7/23 | 3/5/24 | 3/4/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33x | - | - | - | 94.51M | |
| 25.77x | 4.53x | 17.68x | 0.37% | 186B | |
| 55.48x | 14.36x | 33.42x | -.--% | 174B | |
| 30.55x | 5.79x | 18.12x | 0.68% | 138B | |
| 29.14x | 5x | 16.19x | -.--% | 106B | |
| 20.38x | 2.37x | 11.79x | 2.6% | 52.29B | |
| 28.33x | 6.43x | 20.66x | -.--% | 47.42B | |
| 23.89x | 6.31x | 16.2x | 0.96% | 36.67B | |
| 15.36x | 1.75x | 9.46x | 0.22% | 33.85B | |
| 22.08x | 4.53x | 15.69x | 0.89% | 32.52B | |
| Average | 24.86x | 5.67x | 17.69x | 0.63% | 80.75B | |
| Weighted average by Cap. | 32.56x | 6.86x | 20.25x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- STIM Stock
- Valuation Neuronetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
